<SEC-DOCUMENT>0000921895-25-001708.txt : 20250605
<SEC-HEADER>0000921895-25-001708.hdr.sgml : 20250605
<ACCEPTANCE-DATETIME>20250605160951
ACCESSION NUMBER:		0000921895-25-001708
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250605
DATE AS OF CHANGE:		20250605

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EGAIN Corp
		CENTRAL INDEX KEY:			0001066194
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		EIN:				770466366
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-58033
		FILM NUMBER:		251027186

	BUSINESS ADDRESS:	
		STREET 1:		1252 BORREGAS AVENUE
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94089
		BUSINESS PHONE:		6502307500

	MAIL ADDRESS:	
		STREET 1:		1252 BORREGAS AVENUE
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94089

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EGAIN COMMUNICATIONS CORP
		DATE OF NAME CHANGE:	19990709

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Philotimo Fund, LP
		CENTRAL INDEX KEY:			0001688522
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		6810 LYONS TECHNOLOGY CIRCLE
		STREET 2:		SUITE 160
		CITY:			COCONUT CREEK
		STATE:			FL
		ZIP:			33076
		BUSINESS PHONE:		631-863-3100

	MAIL ADDRESS:	
		STREET 1:		6810 LYONS TECHNOLOGY CIRCLE
		STREET 2:		SUITE 160
		CITY:			COCONUT CREEK
		STATE:			FL
		ZIP:			33076
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0000921895-23-000931</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Philotimo Fund, LP -->
          <cik>0001688522</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <dateOfEvent>06/05/2025</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001066194</issuerCIK>
        <issuerCUSIP>28225C806</issuerCUSIP>
        <issuerName>EGAIN Corp</issuerName>
        <address>
          <com:street1>1252 BORREGAS AVENUE</com:street1>
          <com:city>SUNNYVALE</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94089</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>MR. DAVID L. KANEN</personName>
          <personPhoneNum>631-863-3100</personPhoneNum>
          <personAddress>
            <com:street1>KANEN WEALTH MANAGEMENT, LLC</com:street1>
            <com:street2>6810 Lyons Technology Circle, Suite 160</com:street2>
            <com:city>Coconut Creek</com:city>
            <com:stateOrCountry>FL</com:stateOrCountry>
            <com:zipCode>33073</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001688522</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Philotimo Fund, LP</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1738741.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1738741.00</sharedDispositivePower>
        <aggregateAmountOwned>1738741.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.4</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001962162</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Philotimo Focused Growth &amp; Income Fund</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>736732.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>736732.00</sharedDispositivePower>
        <aggregateAmountOwned>736732.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>2.7</percentOfClass>
        <typeOfReportingPerson>OO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001681614</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Kanen Wealth Management LLC</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>AF</fundType>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>FL</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2633391.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2633391.00</sharedDispositivePower>
        <aggregateAmountOwned>2633391.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>9.6</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001681743</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Kanen David</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>AF</fundType>
        <fundType>PF</fundType>
        <fundType>OO</fundType>
        <legalProceedings>Y</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>22429.00</soleVotingPower>
        <sharedVotingPower>2633391.00</sharedVotingPower>
        <soleDispositivePower>22429.00</soleDispositivePower>
        <sharedDispositivePower>2633391.00</sharedDispositivePower>
        <aggregateAmountOwned>2655820.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>9.7</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.001 per share</securityTitle>
        <issuerName>EGAIN Corp</issuerName>
        <issuerPrincipalAddress>
          <com:street1>1252 BORREGAS AVENUE</com:street1>
          <com:city>SUNNYVALE</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94089</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>The following constitutes Amendment No. 3 to the Schedule 13D filed by the undersigned ("Amendment No. 3"). This Amendment No. 3 amends the Schedule 13D as specifically set forth herein. Unless otherwise defined herein, all capitalized terms used herein shall have the meanings given to them in the Schedule 13D.</commentText>
      </item1>
      <item2>
        <filingPersonName>Item 2(a) is hereby amended and restated to read as follows:

This statement is filed by:

(i) Philotimo Fund, LP, a Delaware limited partnership ("Philotimo"), with respect to the Shares beneficially owned by it;

(ii) Philotimo Focused Growth and Income Fund, a series of World Funds Trust, a Delaware statutory trust ("PHLOX"), with respect to the Shares beneficially owned by it;

(iii) Kanen Wealth Management, LLC, a Florida limited liability company ("KWM"), as the general partner of Philotimo and the investment manager of PHLOX and certain separately managed accounts (the "Managed Accounts"); and

(iv) David L. Kanen, as the managing member of KWM.

Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." Each of the Reporting Persons is party to that certain Joint Filing Agreement, as further described in Item 6 to the Schedule 13D. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D.</filingPersonName>
        <convictionDescription>Item 2(e) is hereby amended and restated to read as follows:

During the last five years no Reporting Person was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws, except as described below.

On September 25, 2024, Mr. David L. Kanen, without admitting or denying any findings, consented to the entry of an Order Instituting Cease-and-Desist Proceedings by the Securities and Exchange Commission ("SEC") in settlement of an administrative proceeding that alleges violations of Section 13(d) and Section 16(a) and the rules thereunder for failing to timely file certain beneficial ownership reports on Schedule 13D and Schedule 13G. The order considered remedial acts promptly undertaken by Mr. Kanen and his cooperation and ordered Mr. Kanen to cease and desist from causing any future violations of the charged provisions and imposed a civil monetary penalty of $109,000, which Mr. Kanen has paid in full.</convictionDescription>
      </item2>
      <item3>
        <fundsSource>Item 3 is hereby amended and restated to read as follows:

The Shares purchased by Philotimo were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by PHLOX were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by KWM on behalf of the Managed Accounts were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The aggregate purchase price of the 1,738,741 Shares beneficially owned by Philotimo is approximately $14,183,776, including brokerage commissions. The aggregate purchase price of the 736,732 Shares beneficially owned by PHLOX is approximately $5,960,027, including brokerage commissions. The aggregate purchase price of the 157,918 Shares held in the Managed Accounts is approximately $1,363,956, including brokerage commissions. The aggregate purchase price of the 22,429 Shares beneficially owned by Mr. Kanen is approximately $197,419, including brokerage commissions.</fundsSource>
      </item3>
      <item5>
        <percentageOfClassSecurities>Item 5(a) is hereby amended and restated to read as follows:

The aggregate percentage of Shares reported owned by each person named herein is based upon 27,350,693 Shares outstanding as of May 9, 2025 as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on May 14, 2025.

A. Philotimo
As of the close of business on June 5, 2025, Philotimo beneficially owned 1,738,741 Shares. Percentage: Approximately 6.4%

B. PHLOX
As of the close of business on June 5, 2025, PHLOX beneficially owned 736,732 Shares. Percentage: Approximately 2.7%

C. KWM
As of the close of business on June 5, 2025, KWM beneficially owned 2,633,391 Shares, consisting of (a) the 1,738,741 Shares owned directly by Philotimo, which KWM may be deemed to beneficially own as the general partner of Philotimo, (b) the 736,732 Shares owned directly by PHLOX, which KWM may be deemed to beneficially own as the investment manager of PHLOX and (c) the 157,918 Shares held in the Managed Accounts, which KWM may be deemed to beneficially own as the investment manager of the Managed Accounts. Percentage: Approximately 9.6%

D. Mr. Kanen
As of the close of business on June 5, 2025, Mr. Kanen beneficially owned 2,655,820 Shares, consisting of (a) the 22,429 Shares owned directly by Mr. Kanen, (b) the 1,738,741 Shares owned directly by Philotimo, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM, (c) the 736,732 Shares owned directly by PHLOX, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM, and (d) the 157,918 Shares held in the Managed Accounts, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM. Percentage: Approximately 9.7%.

Each Reporting Person is a member of a "group" with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and such group may be deemed to beneficially own the 2,655,820 Shares beneficially owned in the aggregate by all the Reporting Persons, constituting approximately 9.7% of the outstanding Shares. Each Reporting Person disclaims beneficial ownership of the Shares that he or it does not directly own.</percentageOfClassSecurities>
        <numberOfShares>Item 5(b) is hereby amended and restated to read as follows:

A. Philotimo
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 1,738,741
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 1,738,741

B. PHLOX
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 736,732
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 736,732

C. KWM
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 2,633,391
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 2,633,391

D. Mr. Kanen
1. Sole power to vote or direct vote: 22,429
2. Shared power to vote or direct vote: 2,633,391
3. Sole power to dispose or direct the disposition: 22,429
4. Shared power to dispose or direct the disposition: 2,633,391</numberOfShares>
        <transactionDesc>Item 5(c) is hereby amended and restated to read as follows:

A. Philotimo
Philotimo has not entered into transactions in the Shares during the past sixty days.

B. PHLOX
PHLOX has not entered into transactions in the Shares during the past sixty days.

C. KWM
The transaction in the Shares by KWM during the past sixty days is set forth in Exhibit 1 and is incorporated herein by reference. This transaction was effected in the open market.

D. Mr. Kanen
Mr. Kanen has not entered into transactions in the Shares during the past sixty days.</transactionDesc>
      </item5>
      <item7>
        <filedExhibits>Item 7 is hereby amended to add the following exhibit:

1 - Transactions in Securities</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Philotimo Fund, LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ David L. Kanen</signature>
          <title>David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its general partner</title>
          <date>06/05/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Philotimo Focused Growth &amp; Income Fund</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ David L. Kanen</signature>
          <title>David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its investment adviser</title>
          <date>06/05/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Kanen Wealth Management LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ David L. Kanen</signature>
          <title>David L. Kanen, Managing Member</title>
          <date>06/05/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Kanen David</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ David L. Kanen</signature>
          <title>David L. Kanen</title>
          <date>06/05/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>ex1to13da311527egan_060425.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Exhibit 1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><U>Transaction in the Shares of the Issuer
During the Past Sixty Days</U></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><U>Nature of the Transaction</U></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Amount of Shares</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Purchased/(Sold)</U></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><U>Price ($)</U></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Purchase/Sale</U></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-transform: uppercase"><U>KANEN
WEALTH </U></FONT><U>MANAGEMENT<FONT STYLE="text-transform: uppercase">, llC (</FONT>through the Managed Accounts)</U></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif">Sale of Common Stock</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center">(600)</TD>
    <TD STYLE="white-space: nowrap; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center">5.23</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center">04/29/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
